Symbiotec Pharmalab IPO listing today: Will it list at a premium or discount? Here's what the latest GMP signals

Read post on livemint.com

Symbiotec Pharmalab prepares for its IPO listing today.  Analysts predict a potential 20-22% rise based on the latest grey market premium.